Theralase Technologies (TTX) Ratios
Theralase Technologies Ratios
DE:TTX's free cash flow for Q2 2026 was $-1.23M. For the 2026 fiscal year, DE:TTX's free cash flow was decreased by $-4.54K and operating cash flow was $-1.23M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.25 | 1.61 | 1.39 | 3.67 | 5.71 |
| Quick Ratio | 0.94 | 1.05 | 0.78 | 2.96 | 5.07 |
| Cash Ratio | 0.11 | 0.27 | 0.04 | 2.21 | 4.22 |
| Solvency Ratio | -2.25 | -3.38 | -3.12 | -4.62 | -4.73 |
| Operating Cash Flow Ratio | -2.02 | -3.37 | -3.78 | -7.53 | -4.61 |
| Short-Term Operating Cash Flow Coverage | -12.84 | -33.16 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 310.08K | $ 404.17K | $ 127.56K | $ 1.43M | $ 4.12M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.09 | 0.12 | 0.11 | 0.01 |
| Debt-to-Equity Ratio | 0.26 | 0.14 | 0.20 | 0.15 | 0.01 |
| Debt-to-Capital Ratio | 0.20 | 0.12 | 0.17 | 0.13 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.97 | 1.57 | 1.72 | 1.35 | 1.17 |
| Debt Service Coverage Ratio | -13.12 | -31.82 | -139.92 | -231.26 | -808.11 |
| Interest Coverage Ratio | -99.25 | -177.68 | -151.10 | -244.76 | -845.92 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.07 | -0.01 | -0.08 | 0.21 | 0.85 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.58% | 53.61% | 52.52% | 55.17% | 39.70% |
| EBIT Margin | -499.56% | -409.51% | -424.22% | -457.95% | -564.37% |
| EBITDA Margin | -478.86% | -383.18% | -397.49% | -430.44% | -552.31% |
| Operating Profit Margin | -511.39% | -414.96% | -429.25% | -456.79% | -578.87% |
| Pretax Profit Margin | -504.71% | -411.84% | -427.06% | -459.81% | -565.06% |
| Net Profit Margin | -504.71% | -411.84% | -427.06% | -460.97% | -565.74% |
| Continuous Operations Profit Margin | -504.71% | -411.84% | -427.06% | -459.81% | -565.06% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.25% | 100.12% |
| EBT Per EBIT | 98.69% | 99.25% | 99.49% | 100.66% | 97.61% |
| Return on Assets (ROA) | -117.92% | -131.08% | -139.49% | -126.14% | -74.29% |
| Return on Equity (ROE) | -231.79% | -205.86% | -239.89% | -169.71% | -87.11% |
| Return on Capital Employed (ROCE) | -223.13% | -189.67% | -208.90% | -149.47% | -89.13% |
| Return on Invested Capital (ROIC) | -186.74% | -174.21% | -200.42% | -145.84% | -88.50% |
| Return on Tangible Assets | -117.92% | -131.08% | -139.49% | -126.14% | -74.29% |
| Earnings Yield | -9.87% | -6.69% | -11.54% | -7.89% | -5.69% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.68 | 1.45 | 1.79 | 2.61 | 9.06 |
| Payables Turnover | 0.73 | 1.32 | 0.75 | 1.56 | 0.95 |
| Inventory Turnover | 1.14 | 0.88 | 0.77 | 1.05 | 0.83 |
| Fixed Asset Turnover | 1.82 | 1.71 | 1.25 | 1.03 | 0.90 |
| Asset Turnover | 0.23 | 0.32 | 0.33 | 0.27 | 0.13 |
| Working Capital Turnover Ratio | 1.63 | 2.03 | 0.96 | 0.38 | 0.13 |
| Cash Conversion Cycle | 356.88 | 390.55 | 187.02 | 252.71 | 94.41 |
| Days of Sales Outstanding | 535.71 | 251.30 | 204.13 | 139.97 | 40.31 |
| Days of Inventory Outstanding | 320.74 | 414.98 | 472.75 | 347.22 | 439.05 |
| Days of Payables Outstanding | 499.57 | 275.74 | 489.86 | 234.48 | 384.94 |
| Operating Cycle | 856.45 | 666.28 | 676.87 | 487.19 | 479.35 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.03 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -67.15 | -166.58 | -109.29 | -72.90 | -39.97 |
| Capital Expenditure Coverage Ratio | -67.15 | -166.58 | -109.29 | -72.90 | -39.97 |
| Operating Cash Flow Coverage Ratio | -7.17 | -11.32 | -10.53 | -10.84 | -112.82 |
| Operating Cash Flow to Sales Ratio | -4.02 | -3.22 | -3.81 | -4.51 | -5.16 |
| Free Cash Flow Yield | -7.98% | -5.26% | -10.38% | -7.82% | -5.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.12 | -14.97 | -8.66 | -12.68 | -17.58 |
| Price-to-Sales (P/S) Ratio | 51.16 | 61.56 | 36.99 | 58.44 | 99.44 |
| Price-to-Book (P/B) Ratio | 23.49 | 30.77 | 20.78 | 21.51 | 15.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -12.52 | -19.01 | -9.63 | -12.79 | -18.79 |
| Price-to-Operating Cash Flow Ratio | -12.71 | -19.13 | -9.72 | -12.96 | -19.26 |
| Price-to-Earnings Growth (PEG) Ratio | 1.28 | 1.00 | 0.50 | -0.76 | 0.82 |
| Enterprise Value Multiple | -10.75 | -16.07 | -9.39 | -13.37 | -17.16 |
| Enterprise Value | 42.04M | 63.64M | 39.94M | 65.50M | 73.97M |
| EV to EBITDA | -10.75 | -16.07 | -9.39 | -13.37 | -17.16 |
| EV to Sales | 51.49 | 61.58 | 37.31 | 57.53 | 94.75 |
| EV to Free Cash Flow | -12.61 | -19.02 | -9.72 | -12.59 | -17.90 |
| EV to Operating Cash Flow | -12.80 | -19.13 | -9.81 | -12.76 | -18.35 |
| Tangible Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Shareholders’ Equity Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Net Income Per Share | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.01 | 1.01 | 1.00 | 1.00 |
| Research & Development to Revenue | 2.76 | 2.66 | 2.79 | 3.76 | 3.75 |
| SG&A to Revenue | 2.65 | 1.98 | 1.90 | 1.27 | 2.25 |
| Stock-Based Compensation to Revenue | 0.70 | 0.50 | 0.58 | 0.17 | 0.41 |
| Income Quality | 0.80 | 0.78 | 0.89 | 0.98 | 0.91 |
Currency in CAD